-
A SYSTEMATIC REVIEW OF ONCOLYTIC VIRUSES AND GENE THERAPIES FOR RETINOBLASTOMA IN CHILDREN
Feb 25, 2026, 14:41 PM -
EXPLORING LIFE SATISFACTION AS AN OUTCOME OF INTEREST FOR VALUE ASSESSMENT
Feb 25, 2026, 14:41 PM -
IDENTIFYING (DIS-)AGREEMENT BETWEEN MODELS FOR EVALUATION OF EFFECTIVENESS OF RISK MINIMIZATION MEASURES (RMMS)
Feb 25, 2026, 14:41 PM -
FACTORS ASSOCIATED WITH TREATMENT ENGAGEMENT AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER AFTER DISCHARGE: A RETROSPECTIVE COHORT STUDY
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL AMONG INDIVIDUALS RECEIVING FIRST-LINE TREATMENT FOR BRCA WILD-TYPE ADVANCED EPITHELIAL OVARIAN CANCER: A PATIENT-LEVEL ANALYSIS OF POOLED HISTORICAL CLINICAL TRIALS
Feb 25, 2026, 14:41 PM -
REAL-WORLD PRESCRIPTION PATTERNS, ADHERENCE, AND LDL REDUCTION OF PCSK9 INHIBITOR USERS IN CHINA: EVIDENCE FOLLOWING NRDL INCLUSION
Feb 25, 2026, 14:41 PM -
CLINICAL SIGNIFICANCE OF AVAILABLE DRUG INFORMATION RESOURCES REGARDING DRUG-DRUG INTERACTIONS: AN AUDIT FROM A TERTIARY CARE CANCER CENTRE IN INDIA
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF ACUPUNCTURE TREATMENT COMPARED TO PLACEBO IN VETERANS WITH COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD)
Feb 25, 2026, 14:41 PM -
A SYSTEMATIC LITERATURE REVIEW (SLR) OF THE PREVALENCE, RISK FACTORS, AND SHORT- AND LONG-TERM IMPACT ON HEALTHCARE RESOURCE UTILIZATION (HCRU) OF DELAYED GRAFT FUNCTION (DGF) IN PATIENTS RECEIVING KIDNEY ALLOGRAFTS
Feb 25, 2026, 14:41 PM -
COMPARATIVE EVALUATION OF SUBJECTIVE SLEEP QUALITY AND INSOMNIA ACROSS PSYCHIATRIC DISORDERS: EVIDENCE FROM PATIENT-REPORTED OUTCOME MEASURES
Feb 25, 2026, 14:41 PM -
USE OF REAL-WORLD EVIDENCE IN PRE-APPROVAL ASSESSMENTS FOR RARE AND ULTRA-RARE DISEASE THERAPIES IN UK, GERMANY, FRANCE, AND THE UNITED STATES
Feb 25, 2026, 14:41 PM -
BASELINE (UNTREATED) RISK OF HOSPITALIZATION AND MORTALITY IN PATIENTS WITH SPECIFIC COMORBID HIGH-RISK CONDITIONS WHO ARE ELIGIBLE FOR NIRMATRELVIR/RITONAVIR TREATMENT: A SYSTEMATIC LITERATURE REVIEW EXPANSION STUDY
Feb 25, 2026, 14:41 PM -
THE BUDGET IMPACT OF TUMOR-TREATING FIELDS PLUS GEMCITABINE AND NAB-PACLITAXEL FOR FRONT-LINE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER
Feb 25, 2026, 14:41 PM -
SHAREHOLDERS AND COMMON OWNERSHIP IN THE MARKET FOR MONOCLONAL ANTIBODIES: A NETWORK ANALYSIS
Feb 25, 2026, 14:41 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR METABOLIC DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:41 PM -
PATIENT-REPORTED OUTCOMES-BASED SYMPTOM MONITORING AMONG PATIENTS RECEIVING IMMUNOTHERAPY FOR LUNG CANCER: A RANDOMIZED CONTROLLED TRIAL
Feb 25, 2026, 14:41 PM -
FROM TOKYO TO WASHINGTON: IMPACT OF JAPAN’S HTA ENVIRONMENT ON U.S. MFN PRICING AND LAUNCH STRATEGY
Feb 25, 2026, 14:41 PM -
A STATISTICAL MODELING FRAMEWORK FOR PROCESS-MINED REAL-WORLD DATA SUPPORTING HTA OF MULTIPLE MYELOMA TECHNOLOGIES IN A BRAZILIAN HEALTH MAINTENANCE ORGANIZATION
Feb 25, 2026, 14:41 PM -
HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF HERPES ZOSTER IN IMMUNOCOMPETENT OLDER ADULTS IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY
Feb 25, 2026, 14:41 PM -
GENERIC ENTRY AND THE EARLY IMPACT ON U.S. PHARMACEUTICAL SPENDING
Feb 25, 2026, 14:41 PM
